Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome.

  title={Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome.},
  author={Ivana Rita Maida and Pilar Garc{\'i}a-Gasc{\'o} and Giovanni Sotgiu and Mar{\'i}a Jos{\'e} R{\'i}os and Mar{\'i}a Eugenia Vispo and Luz Mart{\'i}n-Carbonero and Pablo Barreiro and Mar{\'i}a Stella Mura and Sergio Babudieri and Sonia Albertos and J. Garc{\'i}a-samaniego and Vicente Soriano},
  journal={Antiviral therapy},
  volume={13 1},
BACKGROUND Cases of severe unexplained liver disease in HIV-infected individuals have recently been reported and are often associated with exposure to didanosine (ddl) and nodular regenerative hyperplasia. Herein, we examine the clinical outcome following ddl removal. METHODS From 3,300 HIV-infected patients attending three clinics since 2004, all who exhibited persistently elevated aminotransferases and/or significant liver fibrosis in the absence of any known cause of liver damage were… CONTINUE READING

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
45 Extracted Citations
0 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 45 extracted citations

Similar Papers

Loading similar papers…